REGULATED PRESS RELEASE published on 01/12/2026 at 09:00, 2 months 11 days ago Biophytis to Participate in the JP Morgan Healthcare Conference and the Biomed Forum Biophytis announces participation in JP Morgan Healthcare Conference and Biomed Forum in January 2026, presenting latest operational and clinical progress Biophytis BIOMED Forum Age-related Diseases JP Morgan Healthcare Conference Transformative Therapies
REGULATED PRESS RELEASE published on 01/12/2026 at 09:00, 2 months 11 days ago Biophytis participe à la JP Morgan Healthcare Conference et au Biomed Forum Biophytis participe à la JP Morgan Healthcare Conference et au Biomed Forum pour présenter ses avancées opérationnelles et cliniques, ainsi que ses perspectives de développement pour 2026 Biophytis Développement BIOMED Forum Santé JP Morgan Healthcare Conference
PRESS RELEASE published on 01/12/2026 at 08:59, 2 months 11 days ago Biophytis participe à la JP Morgan Healthcare Conference et au Biomed Forum Biophytis annonce sa participation à la JP Morgan Healthcare Conference et au Biomed Forum pour échanger avec la communauté financière et pharmaceutique Biophytis BIOMED Forum JP Morgan Healthcare Conference Développement Thérapies Santé Investissement
PRESS RELEASE published on 01/12/2026 at 08:59, 2 months 11 days ago Biophytis to Participate in the JP Morgan Healthcare Conference and the Biomed Forum Biophytis to participate in JP Morgan Healthcare Conference and Biomed Forum to engage with global financial and pharmaceutical communities for 2026 outlook Biophytis BIOMED Forum Healthcare Conference JP Morgan 2026
BRIEF published on 11/13/2025 at 18:35, 4 months 9 days ago Biophytis : Résultats de l'Assemblée Générale du 13 Novembre 2025 Biophytis Assemblée Générale Resolutions Quorum Thérapies Longues Vie
BRIEF published on 11/13/2025 at 18:35, 4 months 9 days ago Results of Biophytis' General Meeting Held on November 13, 2025 Financial Statements Biophytis Shareholder Approval General Meeting Thérapies
REGULATED PRESS RELEASE published on 11/13/2025 at 18:30, 4 months 9 days ago RESULTS OF THE COMBINED GENERAL MEETING ON NOVEMBER 13, 2025 Biophytis SA announces the approval of all resolutions at the combined general meeting held on November 13, 2025, impacting longevity therapies development. Shareholder mobilization led to a 31% quorum Longevity Therapies Combined General Meeting Biophytis SA Shareholder Mobilization Approval Of Resolutions
REGULATED PRESS RELEASE published on 11/13/2025 at 18:30, 4 months 9 days ago RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 13 NOVEMBRE 2025 Biophytis annonce l'adoption des résolutions lors de son assemblée générale mixte du 13 novembre 2025, incluant l'approbation des comptes 2024 Biophytis Assemblée Générale Resolutions Résultats Votes Développement Thérapies
BRIEF published on 10/30/2025 at 23:05, 4 months 23 days ago Biophytis Announces Strategic Partnerships and Financial Results for H1 2025 Financial Results Strategic Partnerships Obesity Treatment Sarcopenia Clinical Trial Biophytis Expansion
BRIEF published on 10/30/2025 at 23:05, 4 months 23 days ago Biophytis : résultats du premier semestre 2025 et nouvelles stratégies Stratégie Biophytis Financement Sarcopénie Obésité
Published on 03/23/2026 at 14:05, 3 hours 25 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 3 hours 30 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 4 hours 25 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 4 hours 58 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 5 hours ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 17:00, 30 minutes ago Phuket consolide sa position privilégiée pour les familles du monde entier en quête d’un lieu de résidence sûr
Published on 03/23/2026 at 16:20, 1 hour 10 minutes ago Switzerland Remove Niels Troost from Sanctions
Published on 03/23/2026 at 15:05, 2 hours 25 minutes ago Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 2 hours 48 minutes ago CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 3 hours ago Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 08:10, 9 hours 20 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 22 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 22 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 23 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 23 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
